Eli Lilly has agreed to a $15 million settlement with Alaska over the drug Zyprexa, used a drug to treat schizohprenia and bipolar disorder. The settlement ended a jury trial which began March 6 in Anchorage Superior Court, in which Alaska asked for $270 million for the drug used in its Medicaid program. Reuters reports that Conn. brought a similar law suit on March 11. The company has paid out more than $1.2 billion to settle 30,000 individual law suits.
Consider This
by Phyllis Vine
MIWatch.org on Facebook
Relevant Sites
- Visit the Illinois neurology department of Northshore
Featured Videos
Most Popular
MIWatch Archives
This site complies with the HONcode standard for trustworthy health information:
verify here.
